Apatinib modulates sorafenib-resistant hepatocellular carcinoma through inhibiting the EGFR/JNK/ERK signaling pathway
Oncology Research · 2025
DOI: 10.32604/or.2025.060407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Dexue Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China. Hauptthemen laut MEDLINE: Sorafenib, Pyridines, Liver Neoplasms, Drug Resistance, Neoplasm. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
- Liver Gall Bladder and Pancreatic Surgery Ward, Qinghai Red Cross Hospital, Xining, 810001, China.
- Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, Jinan, 250021, China.
- Departments of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
- Department of Pediatric Surgery, Shandong Provincial Hospital, Shandong University, Jinan, 250021, China.
Zitieren
APA
Fan, D., Su, W., Bi, Z., Wang, X., Xu, X., Ma, M., Zhu, L., Zhang, Z., & Gao, J. (2025). Apatinib modulates sorafenib-resistant hepatocellular carcinoma through inhibiting the EGFR/JNK/ERK signaling pathway. Oncology Research. https://doi.org/10.32604/or.2025.060407
Vancouver
Fan D, Su W, Bi Z, Wang X, Xu X, Ma M, et al. Apatinib modulates sorafenib-resistant hepatocellular carcinoma through inhibiting the EGFR/JNK/ERK signaling pathway. Oncology Research. 2025. doi:10.32604/or.2025.060407
BibTeX
@article{Fan2025,
author = {Fan, Dexue and Su, Wei and Bi, Zhaowen and Wang, Xinxing and Xu, Xianwen and Ma, Mingze and Zhu, Lichao and Zhang, Zhenhai and Gao, Junlin},
title = {Apatinib modulates sorafenib-resistant hepatocellular carcinoma through inhibiting the EGFR/JNK/ERK signaling pathway},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2025.060407}
}
EUVIMED